Yonghui Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Ex vivo pretreatment with venetoclax boosts the antileukemic efficacy of therapeutic γδ T cells in AML models.
Journal: The Journal of clinical investigation
Published: July 23, 2026
Corrigendum to "TGase-mediated cell membrane modification and targeted cell delivery to inflammatory endothelium" [Biomaterials, Volume 269, February 2021, 120276].
Journal: Biomaterials
Published: July 26, 2025
Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.
Journal: Nature communications
Published: January 03, 2025
TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.
Journal: Nature communications
Published: December 20, 2023
Correction to: MARCKS regulates tonic and chronic active B cell receptor signaling.
Journal: Leukemia
Published: December 01, 2023
Correction: Farnesyl pyrophosphate is a new danger signal inducing acute cell death.
Journal: PLoS biology
Published: November 15, 2023
KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge.
Journal: Cell discovery
Published: June 22, 2021
Farnesyl pyrophosphate is a new danger signal inducing acute cell death.
Journal: PLoS biology
Published: May 13, 2020
TGase-mediated cell membrane modification and targeted cell delivery to inflammatory endothelium.
Journal: Biomaterials
Published: April 02, 2020
VISAR: an interactive tool for dissecting chemical features learned by deep neural network QSAR models.
Journal: Bioinformatics (Oxford, England)
Published: September 03, 2019
Last Updated: 09/26/2026